On March 8, 2022 GlycoMimetics, Inc. (Nasdaq: GLYC) reported that the Company will participate at the 34th Annual Roth Conference in Laguna Niguel, California, March 14 and 15 (Press release, GlycoMimetics, MAR 8, 2022, View Source [SID1234609661]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Chief Executive Officer Harout Semerjian and Chief Financial Officer Brian Hahn will attend in person. Research Analyst Zegbeh Jallah, Ph.D. will host a fireside chat with Mr. Semerjian. An archived recording of the chat will be available for thirty days on the GlycoMimetics website at View Source, beginning Tuesday, March 15 at approximately 2:00 p.m. PST.